GPRC5A and breast carcinoma: For example, evidence described an increased expression of RAI3 in 19 of 25 primary breast cancers and 6 of 11 breast cancer cell lines in comparison to normal tissues, and the suppression of cancer cell growth after transfection with RAI3 siRNA [244].